Literature DB >> 27125487

Full-Genome Sequences of Seven Fatal Enterovirus 71 Strains Isolated in Shenzhen, China, in 2014.

Long Chen1, Ya-Qing He1, Jun Meng1, Ling-Hong Xiong1, Chao Wang1, Xiang-Jie Yao1, Hai-Long Zhang1, Ren-Li Zhang1, Hong Yang2.   

Abstract

The whole-genome sequences of seven fatal enterovirus 71 (EV71) strains, isolated in southern China, in 2014, were determined. The complete genome sequences of these strains displayed close relationships to native EV71 strains and showed 94.2% to 99.8% identity to each other. All of these strains were assigned to subgenotype C4a based on phylogenetic analysis of the VP1 gene.
Copyright © 2016 Chen et al.

Entities:  

Year:  2016        PMID: 27125487      PMCID: PMC4850858          DOI: 10.1128/genomeA.00316-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Enterovirus 71 (EV71), a member of the enterovirus A species of the family Picornaviridae, is the most common pathogen of hand, foot, and mouth disease (HFMD) in children and infants (1, 2). Enteroviruses are a group of naked positive single-stranded RNA viruses, and their genome comprises a 5′ untranslated region (UTR), structural polypeptide P1, nonstructural polypeptides P2 and P3, and a 3′ untranslated region (3). Based on phylogenetic analysis of the VP1 genes, worldwide EV71 strains were classified into 3 main genogroups (A, B, and C) and 12 subgenotypes (A, B0 to B5, and C1 to C5) (4–6). Epidemic waves of EV71 infections have swept through countries in the Asia-Pacific region since 1997 (7, 8). Although the globally emerging pathogen coxsackievirus A6 (CV-A6) has tended to predominate over EV71 as the etiologic agent of HFMD since 2013, EV71 is still responsible for severe HFMD and even death (9–11). From March 2014 to September 2014, the Shenzhen Center for Disease Control and Prevention (CDC) received death reports of eight children with severe HFMD infections. Fecal specimens or anal swabs from these cases were archived at the Department of Microbiology, Shenzhen CDC. Seven of 8 specimens (87.5%) were detected as positive for EV71 by real-time reverse transcription-PCR (RT-PCR), and the other specimen (1/8 [12.5%]) was detected as positive for CV-A16 (12). Next, these strains were isolated by culturing clinical samples in rhabdomyosarcoma (RD) cell lines. Detailed epidemiological data for seven fatal EV71 strains are listed in Table 1.
TABLE 1

Epidemiological data for seven fatal EV71 strains from this study

IsolateGenderAge (yr)Clinical manifestationAccession no.
EV71/SZ04/CHN/2014Female1.6Fever; rash; vesicles on hands and buttocks; pharyngalgia; lethargy; polypnea; rapid heart rate; muscle twitching; abnormal eye movements; and aseptic encephalitisKT428644
EV71/SZ07/CHN/2014Female1.2Fever; rash; polypnea; cold limbs; shock; and bronchopneumoniaKT428645
EV71/SZ12/CHN/2014Male2.5Fever; rash; vesicles on hands, foot, and mouth; polypnea; and aseptic encephalitisKT428646
EV71/SZ25/CHN/2014Male2.6Fever; rash; vesicles on hands, foot, and mouth; polypnea; rapid heart rate; and muscle twitchingKT428647
EV71/SZ42/CHN/2014Male4.3Fever; vesicles on hands, foot, mouth, knees, and buttocksKT428648
EV71/SZ50/CHN/2014Male3.0Fever; rash; vesicles on hands, foot, and buttocks; muscle twitchingKT428649
EV71/SZ88/CHN/2014Male1.9Fever; rash; vesicles on hands, foot, mouth, elbow, knees, and buttocks; cough; lethargy; polypnea; rapid heart rate; muscle twitching; and aseptic encephalitisKT428650
Epidemiological data for seven fatal EV71 strains from this study A pair of universal primers, EVA-F30 (5′-TTAAAACAGCCTGTGGGTTGTACCCACCCA-3′) and EVA-R36 (5′-GCTATTCTGGTTATAACAAATTTACCCCCACCAGTC-3′), were used to amplify full-length genomes of these strains by a one-step RT-PCR method, as described previously (12). Amplified DNA products were sequenced by TaKaRa (Japan) using a primer-walking method. Contigs were assembled using sequencer version 4.9. The raw genome sequences were examined using BioEdit version 7.2.5 before submission to GenBank. Molecular phylogeny was investigated using the program MEGA 6.06 (13). The complete genome sequences of seven EV71 strains were composed of 7,405 nucleotides (nt), excluding the poly(A) tail. The 5′-UTR was found to be 742 nt, followed by an open reading frame (ORF) encoding the structural protein P1 (2,586 nt), the nonstructural proteins P2 (1,734 nt) and P3 (2,259 nt), and the 3′-UTR (81 nt). The contents of A, C, G, and U of the seven EV71 genome sequences were 27.05 to 27.27%, 23.97 to 24.19%, 23.70 to 23.92%, and 24.83 to 25.02%, respectively, with G+C contents of 47.67 to 48.11%. The full-length genome sequences of these strains displayed close relationships to native EV71 strains and showed 94.2 to 99.8% identity to each other. All of these strains were assigned to subgenotype C4a based on phylogenetic analysis of the VP1 gene. To date, a vaccine against EV71 has not been commercially introduced (14, 15), but family- and kindergarten-based early intervention programs and timely treatment may reduce the incidence of severe and fatal cases.

Nucleotide sequence accession numbers.

The full-length genome sequences of seven fatal EV71 isolates have been deposited in GenBank under the accession numbers listed in Table 1.
  15 in total

1.  MEGA6: Molecular Evolutionary Genetics Analysis version 6.0.

Authors:  Koichiro Tamura; Glen Stecher; Daniel Peterson; Alan Filipski; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2013-10-16       Impact factor: 16.240

2.  Evolutionary trajectory of the VP1 gene of human enterovirus 71 genogroup B and C viruses.

Authors:  Sabine van der Sanden; Harrie van der Avoort; Philippe Lemey; Gökhan Uslu; Marion Koopmans
Journal:  J Gen Virol       Date:  2010-04-07       Impact factor: 3.891

Review 3.  Virology, epidemiology, pathogenesis, and control of enterovirus 71.

Authors:  Tom Solomon; Penny Lewthwaite; David Perera; Mary Jane Cardosa; Peter McMinn; Mong How Ooi
Journal:  Lancet Infect Dis       Date:  2010-10-18       Impact factor: 25.071

Review 4.  Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide.

Authors:  Lianlian Bian; Yiping Wang; Xin Yao; Qunying Mao; Miao Xu; Zhenglun Liang
Journal:  Expert Rev Anti Infect Ther       Date:  2015-06-25       Impact factor: 5.091

5.  Transmission patterns of human enterovirus 71 to, from and among European countries, 2003 to 2013.

Authors:  Chervin Hassel; Audrey Mirand; Alexander Lukashev; Elena TerletskaiaLadwig; Agnes Farkas; Isabelle Schuffenecker; Sabine Diedrich; Hartwig P Huemer; Christine Archimbaud; Hélène Peigue-Lafeuille; Cécile Henquell; Jean-Luc Bailly
Journal:  Euro Surveill       Date:  2015

6.  Complete genome sequences of all members of the species Human enterovirus A.

Authors:  M Steven Oberste; Silvia Peñaranda; Kaija Maher; Mark A Pallansch
Journal:  J Gen Virol       Date:  2004-06       Impact factor: 3.891

Review 7.  Clinical features, diagnosis, and management of enterovirus 71.

Authors:  Mong How Ooi; See Chang Wong; Penny Lewthwaite; Mary Jane Cardosa; Tom Solomon
Journal:  Lancet Neurol       Date:  2010-11       Impact factor: 44.182

8.  Complete genome sequence of a coxsackievirus a16 strain, isolated from a fatal case in shenzhen, southern china, in 2014.

Authors:  Long Chen; Hong Yang; Qian-Jin Feng; Xiang-Jie Yao; Hai-Long Zhang; Ren-Li Zhang; Ya-Qing He
Journal:  Genome Announc       Date:  2015-04-30

Review 9.  Epidemiological Research on Hand, Foot, and Mouth Disease in Mainland China.

Authors:  Zhi-Chao Zhuang; Zeng-Qiang Kou; Yong-Juan Bai; Xiang Cong; Li-Hong Wang; Chun Li; Li Zhao; Xue-Jie Yu; Zhi-Yu Wang; Hong-Ling Wen
Journal:  Viruses       Date:  2015-12-07       Impact factor: 5.048

Review 10.  Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines.

Authors:  Qingyong Ng; Fang He; Jimmy Kwang
Journal:  Viruses       Date:  2015-12-08       Impact factor: 5.048

View more
  1 in total

1.  N-Acetyltransferase 8 Promotes Viral Replication by Increasing the Stability of Enterovirus 71 Nonstructural Proteins.

Authors:  Xiaohui Zhao; Huijun Yuan; Hang Yang; Yan Liu; Meng Xun; Xiaozhen Li; Tingting Fan; Bo Wu; Shangrui Guo; Hongliang Wang
Journal:  J Virol       Date:  2022-02-16       Impact factor: 6.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.